Global Polypeptide Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Polypeptide Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Polypeptide Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Polypeptide Drug by Country/Region, 2017, 2022 & 2028

2.2 Polypeptide Drug Segment by Type

2.2.1 Injection

2.2.2 Nasal Administration

2.2.3 Lung Administration

2.2.4 Oral Administration

2.2.5 Transdermal Administration

2.3 Polypeptide Drug Sales by Type

2.3.1 Global Polypeptide Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Polypeptide Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Polypeptide Drug Sale Price by Type (2017-2022)

2.4 Polypeptide Drug Segment by Application

2.4.1 Immunity Regulating Medicine (Allergy Infection and Immune)

2.4.2 Digestive System Drugs (Gastrointestinal Type)

2.4.3 Bone and Connective Tissue Types (Thyroid hormones Drug)

2.4.4 Gynecologic or Obstetric Drug

2.4.5 Tumor Drug

2.4.6 Urinary System Drug

2.4.7 Metabolic Drug (Insulin and Other Hypoglycemic Agents)

2.5 Polypeptide Drug Sales by Application

2.5.1 Global Polypeptide Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Polypeptide Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Polypeptide Drug Sale Price by Application (2017-2022)

3 Global Polypeptide Drug by Company

3.1 Global Polypeptide Drug Breakdown Data by Company

3.1.1 Global Polypeptide Drug Annual Sales by Company (2020-2022)

3.1.2 Global Polypeptide Drug Sales Market Share by Company (2020-2022)

3.2 Global Polypeptide Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Polypeptide Drug Revenue by Company (2020-2022)

3.2.2 Global Polypeptide Drug Revenue Market Share by Company (2020-2022)

3.3 Global Polypeptide Drug Sale Price by Company

3.4 Key Manufacturers Polypeptide Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Polypeptide Drug Product Location Distribution

3.4.2 Players Polypeptide Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Polypeptide Drug by Geographic Region

4.1 World Historic Polypeptide Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Polypeptide Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Polypeptide Drug Annual Revenue by Geographic Region

4.2 World Historic Polypeptide Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Polypeptide Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Polypeptide Drug Annual Revenue by Country/Region

4.3 Americas Polypeptide Drug Sales Growth

4.4 APAC Polypeptide Drug Sales Growth

4.5 Europe Polypeptide Drug Sales Growth

4.6 Middle East & Africa Polypeptide Drug Sales Growth

5 Americas

5.1 Americas Polypeptide Drug Sales by Country

5.1.1 Americas Polypeptide Drug Sales by Country (2017-2022)

5.1.2 Americas Polypeptide Drug Revenue by Country (2017-2022)

5.2 Americas Polypeptide Drug Sales by Type

5.3 Americas Polypeptide Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Polypeptide Drug Sales by Region

6.1.1 APAC Polypeptide Drug Sales by Region (2017-2022)

6.1.2 APAC Polypeptide Drug Revenue by Region (2017-2022)

6.2 APAC Polypeptide Drug Sales by Type

6.3 APAC Polypeptide Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Polypeptide Drug by Country

7.1.1 Europe Polypeptide Drug Sales by Country (2017-2022)

7.1.2 Europe Polypeptide Drug Revenue by Country (2017-2022)

7.2 Europe Polypeptide Drug Sales by Type

7.3 Europe Polypeptide Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Polypeptide Drug by Country

8.1.1 Middle East & Africa Polypeptide Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Polypeptide Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Polypeptide Drug Sales by Type

8.3 Middle East & Africa Polypeptide Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Polypeptide Drug

10.3 Manufacturing Process Analysis of Polypeptide Drug

10.4 Industry Chain Structure of Polypeptide Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Polypeptide Drug Distributors

11.3 Polypeptide Drug Customer

12 World Forecast Review for Polypeptide Drug by Geographic Region

12.1 Global Polypeptide Drug Market Size Forecast by Region

12.1.1 Global Polypeptide Drug Forecast by Region (2023-2028)

12.1.2 Global Polypeptide Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Polypeptide Drug Forecast by Type

12.7 Global Polypeptide Drug Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Polypeptide Drug Product Offered

13.1.3 Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 Merck Serono

13.2.1 Merck Serono Company Information

13.2.2 Merck Serono Polypeptide Drug Product Offered

13.2.3 Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Serono Main Business Overview

13.2.5 Merck Serono Latest Developments

13.3 Ferring Pharmaceuticals

13.3.1 Ferring Pharmaceuticals Company Information

13.3.2 Ferring Pharmaceuticals Polypeptide Drug Product Offered

13.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Ferring Pharmaceuticals Main Business Overview

13.3.5 Ferring Pharmaceuticals Latest Developments

13.4 Ipsen PHarma Biotech

13.4.1 Ipsen PHarma Biotech Company Information

13.4.2 Ipsen PHarma Biotech Polypeptide Drug Product Offered

13.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ipsen PHarma Biotech Main Business Overview

13.4.5 Ipsen PHarma Biotech Latest Developments

13.5 Lilly

13.5.1 Lilly Company Information

13.5.2 Lilly Polypeptide Drug Product Offered

13.5.3 Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Lilly Main Business Overview

13.5.5 Lilly Latest Developments

13.6 Asahi Kasei

13.6.1 Asahi Kasei Company Information

13.6.2 Asahi Kasei Polypeptide Drug Product Offered

13.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Asahi Kasei Main Business Overview

13.6.5 Asahi Kasei Latest Developments

13.7 AstraZeneca

13.7.1 AstraZeneca Company Information

13.7.2 AstraZeneca Polypeptide Drug Product Offered

13.7.3 AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 AstraZeneca Main Business Overview

13.7.5 AstraZeneca Latest Developments

13.8 SciClone Pharmaceuticals

13.8.1 SciClone Pharmaceuticals Company Information

13.8.2 SciClone Pharmaceuticals Polypeptide Drug Product Offered

13.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 SciClone Pharmaceuticals Main Business Overview

13.8.5 SciClone Pharmaceuticals Latest Developments

13.9 Takeda

13.9.1 Takeda Company Information

13.9.2 Takeda Polypeptide Drug Product Offered

13.9.3 Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Takeda Main Business Overview

13.9.5 Takeda Latest Developments

13.10 Roche

13.10.1 Roche Company Information

13.10.2 Roche Polypeptide Drug Product Offered

13.10.3 Roche Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Roche Main Business Overview

13.10.5 Roche Latest Developments

13.11 Sanofi

13.11.1 Sanofi Company Information

13.11.2 Sanofi Polypeptide Drug Product Offered

13.11.3 Sanofi Polypeptide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sanofi Main Business Overview

13.11.5 Sanofi Latest Developments

14 Research Findings and Conclusion

Table 1. Polypeptide Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Polypeptide Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Injection

Table 4. Major Players of Nasal Administration

Table 5. Major Players of Lung Administration

Table 6. Major Players of Oral Administration

Table 7. Major Players of Transdermal Administration

Table 8. Global Polypeptide Drug Sales by Type (2017-2022) & (MT)

Table 9. Global Polypeptide Drug Sales Market Share by Type (2017-2022)

Table 10. Global Polypeptide Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Polypeptide Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Polypeptide Drug Sale Price by Type (2017-2022) & (USD/MT)

Table 13. Global Polypeptide Drug Sales by Application (2017-2022) & (MT)

Table 14. Global Polypeptide Drug Sales Market Share by Application (2017-2022)

Table 15. Global Polypeptide Drug Revenue by Application (2017-2022)

Table 16. Global Polypeptide Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Polypeptide Drug Sale Price by Application (2017-2022) & (USD/MT)

Table 18. Global Polypeptide Drug Sales by Company (2020-2022) & (MT)

Table 19. Global Polypeptide Drug Sales Market Share by Company (2020-2022)

Table 20. Global Polypeptide Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Polypeptide Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Polypeptide Drug Sale Price by Company (2020-2022) & (USD/MT)

Table 23. Key Manufacturers Polypeptide Drug Producing Area Distribution and Sales Area

Table 24. Players Polypeptide Drug Products Offered

Table 25. Polypeptide Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Polypeptide Drug Sales by Geographic Region (2017-2022) & (MT)

Table 29. Global Polypeptide Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Polypeptide Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Polypeptide Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Polypeptide Drug Sales by Country/Region (2017-2022) & (MT)

Table 33. Global Polypeptide Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Polypeptide Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Polypeptide Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Polypeptide Drug Sales by Country (2017-2022) & (MT)

Table 37. Americas Polypeptide Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Polypeptide Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Polypeptide Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Polypeptide Drug Sales by Type (2017-2022) & (MT)

Table 41. Americas Polypeptide Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Polypeptide Drug Sales by Application (2017-2022) & (MT)

Table 43. Americas Polypeptide Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Polypeptide Drug Sales by Region (2017-2022) & (MT)

Table 45. APAC Polypeptide Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Polypeptide Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Polypeptide Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Polypeptide Drug Sales by Type (2017-2022) & (MT)

Table 49. APAC Polypeptide Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Polypeptide Drug Sales by Application (2017-2022) & (MT)

Table 51. APAC Polypeptide Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Polypeptide Drug Sales by Country (2017-2022) & (MT)

Table 53. Europe Polypeptide Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Polypeptide Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Polypeptide Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Polypeptide Drug Sales by Type (2017-2022) & (MT)

Table 57. Europe Polypeptide Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Polypeptide Drug Sales by Application (2017-2022) & (MT)

Table 59. Europe Polypeptide Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Polypeptide Drug Sales by Country (2017-2022) & (MT)

Table 61. Middle East & Africa Polypeptide Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Polypeptide Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Polypeptide Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Polypeptide Drug Sales by Type (2017-2022) & (MT)

Table 65. Middle East & Africa Polypeptide Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Polypeptide Drug Sales by Application (2017-2022) & (MT)

Table 67. Middle East & Africa Polypeptide Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Polypeptide Drug

Table 69. Key Market Challenges & Risks of Polypeptide Drug

Table 70. Key Industry Trends of Polypeptide Drug

Table 71. Polypeptide Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Polypeptide Drug Distributors List

Table 74. Polypeptide Drug Customer List

Table 75. Global Polypeptide Drug Sales Forecast by Region (2023-2028) & (MT)

Table 76. Global Polypeptide Drug Sales Market Forecast by Region

Table 77. Global Polypeptide Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Polypeptide Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Polypeptide Drug Sales Forecast by Country (2023-2028) & (MT)

Table 80. Americas Polypeptide Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Polypeptide Drug Sales Forecast by Region (2023-2028) & (MT)

Table 82. APAC Polypeptide Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Polypeptide Drug Sales Forecast by Country (2023-2028) & (MT)

Table 84. Europe Polypeptide Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Polypeptide Drug Sales Forecast by Country (2023-2028) & (MT)

Table 86. Middle East & Africa Polypeptide Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Polypeptide Drug Sales Forecast by Type (2023-2028) & (MT)

Table 88. Global Polypeptide Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Polypeptide Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Polypeptide Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Polypeptide Drug Sales Forecast by Application (2023-2028) & (MT)

Table 92. Global Polypeptide Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Polypeptide Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Polypeptide Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. Novartis Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. Novartis Polypeptide Drug Product Offered

Table 97. Novartis Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 98. Novartis Main Business

Table 99. Novartis Latest Developments

Table 100. Merck Serono Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Merck Serono Polypeptide Drug Product Offered

Table 102. Merck Serono Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 103. Merck Serono Main Business

Table 104. Merck Serono Latest Developments

Table 105. Ferring Pharmaceuticals Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. Ferring Pharmaceuticals Polypeptide Drug Product Offered

Table 107. Ferring Pharmaceuticals Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 108. Ferring Pharmaceuticals Main Business

Table 109. Ferring Pharmaceuticals Latest Developments

Table 110. Ipsen PHarma Biotech Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. Ipsen PHarma Biotech Polypeptide Drug Product Offered

Table 112. Ipsen PHarma Biotech Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 113. Ipsen PHarma Biotech Main Business

Table 114. Ipsen PHarma Biotech Latest Developments

Table 115. Lilly Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. Lilly Polypeptide Drug Product Offered

Table 117. Lilly Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 118. Lilly Main Business

Table 119. Lilly Latest Developments

Table 120. Asahi Kasei Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. Asahi Kasei Polypeptide Drug Product Offered

Table 122. Asahi Kasei Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 123. Asahi Kasei Main Business

Table 124. Asahi Kasei Latest Developments

Table 125. AstraZeneca Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. AstraZeneca Polypeptide Drug Product Offered

Table 127. AstraZeneca Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 128. AstraZeneca Main Business

Table 129. AstraZeneca Latest Developments

Table 130. SciClone Pharmaceuticals Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. SciClone Pharmaceuticals Polypeptide Drug Product Offered

Table 132. SciClone Pharmaceuticals Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 133. SciClone Pharmaceuticals Main Business

Table 134. SciClone Pharmaceuticals Latest Developments

Table 135. Takeda Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. Takeda Polypeptide Drug Product Offered

Table 137. Takeda Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 138. Takeda Main Business

Table 139. Takeda Latest Developments

Table 140. Roche Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 141. Roche Polypeptide Drug Product Offered

Table 142. Roche Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 143. Roche Main Business

Table 144. Roche Latest Developments

Table 145. Sanofi Basic Information, Polypeptide Drug Manufacturing Base, Sales Area and Its Competitors

Table 146. Sanofi Polypeptide Drug Product Offered

Table 147. Sanofi Polypeptide Drug Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 148. Sanofi Main Business

Table 149. Sanofi Latest Developments

List of Figures

Figure 1. Picture of Polypeptide Drug

Figure 2. Polypeptide Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Polypeptide Drug Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Polypeptide Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Polypeptide Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Injection

Figure 10. Product Picture of Nasal Administration

Figure 11. Product Picture of Lung Administration

Figure 12. Product Picture of Oral Administration

Figure 13. Product Picture of Transdermal Administration

Figure 14. Global Polypeptide Drug Sales Market Share by Type in 2021

Figure 15. Global Polypeptide Drug Revenue Market Share by Type (2017-2022)

Figure 16. Polypeptide Drug Consumed in Immunity Regulating Medicine (Allergy Infection and Immune)

Figure 17. Global Polypeptide Drug Market: Immunity Regulating Medicine (Allergy Infection and Immune) (2017-2022) & (MT)

Figure 18. Polypeptide Drug Consumed in Digestive System Drugs (Gastrointestinal Type)

Figure 19. Global Polypeptide Drug Market: Digestive System Drugs (Gastrointestinal Type) (2017-2022) & (MT)

Figure 20. Polypeptide Drug Consumed in Bone and Connective Tissue Types (Thyroid hormones Drug)

Figure 21. Global Polypeptide Drug Market: Bone and Connective Tissue Types (Thyroid hormones Drug) (2017-2022) & (MT)

Figure 22. Polypeptide Drug Consumed in Gynecologic or Obstetric Drug

Figure 23. Global Polypeptide Drug Market: Gynecologic or Obstetric Drug (2017-2022) & (MT)

Figure 24. Polypeptide Drug Consumed in Tumor Drug

Figure 25. Global Polypeptide Drug Market: Tumor Drug (2017-2022) & (MT)

Figure 26. Polypeptide Drug Consumed in Urinary System Drug

Figure 27. Global Polypeptide Drug Market: Urinary System Drug (2017-2022) & (MT)

Figure 28. Polypeptide Drug Consumed in Metabolic Drug (Insulin and Other Hypoglycemic Agents)

Figure 29. Global Polypeptide Drug Market: Metabolic Drug (Insulin and Other Hypoglycemic Agents) (2017-2022) & (MT)

Figure 30. Global Polypeptide Drug Sales Market Share by Application (2017-2022)

Figure 31. Global Polypeptide Drug Revenue Market Share by Application in 2021

Figure 32. Polypeptide Drug Revenue Market by Company in 2021 ($ Million)

Figure 33. Global Polypeptide Drug Revenue Market Share by Company in 2021

Figure 34. Global Polypeptide Drug Sales Market Share by Geographic Region (2017-2022)

Figure 35. Global Polypeptide Drug Revenue Market Share by Geographic Region in 2021

Figure 36. Global Polypeptide Drug Sales Market Share by Region (2017-2022)

Figure 37. Global Polypeptide Drug Revenue Market Share by Country/Region in 2021

Figure 38. Americas Polypeptide Drug Sales 2017-2022 (MT)

Figure 39. Americas Polypeptide Drug Revenue 2017-2022 ($ Millions)

Figure 40. APAC Polypeptide Drug Sales 2017-2022 (MT)

Figure 41. APAC Polypeptide Drug Revenue 2017-2022 ($ Millions)

Figure 42. Europe Polypeptide Drug Sales 2017-2022 (MT)

Figure 43. Europe Polypeptide Drug Revenue 2017-2022 ($ Millions)

Figure 44. Middle East & Africa Polypeptide Drug Sales 2017-2022 (MT)

Figure 45. Middle East & Africa Polypeptide Drug Revenue 2017-2022 ($ Millions)

Figure 46. Americas Polypeptide Drug Sales Market Share by Country in 2021

Figure 47. Americas Polypeptide Drug Revenue Market Share by Country in 2021

Figure 48. United States Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Canada Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Mexico Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Brazil Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. APAC Polypeptide Drug Sales Market Share by Region in 2021

Figure 53. APAC Polypeptide Drug Revenue Market Share by Regions in 2021

Figure 54. China Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Japan Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. South Korea Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Southeast Asia Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. India Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Australia Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Europe Polypeptide Drug Sales Market Share by Country in 2021

Figure 61. Europe Polypeptide Drug Revenue Market Share by Country in 2021

Figure 62. Germany Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. France Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. UK Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Italy Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Russia Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Middle East & Africa Polypeptide Drug Sales Market Share by Country in 2021

Figure 68. Middle East & Africa Polypeptide Drug Revenue Market Share by Country in 2021

Figure 69. Egypt Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 70. South Africa Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 71. Israel Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 72. Turkey Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 73. GCC Country Polypeptide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 74. Manufacturing Cost Structure Analysis of Polypeptide Drug in 2021

Figure 75. Manufacturing Process Analysis of Polypeptide Drug

Figure 76. Industry Chain Structure of Polypeptide Drug

Figure 77. Channels of Distribution

Figure 78. Distributors Profiles